Bayer appoints Simon Rosof as Head of Asia Pacific Pharmaceuticals
Rosof assumes regional leadership role and will also oversee the ASEAN cluster from Singapore
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
Bayer
Bayer expands indication of Kerendia in India
Bayer announced that its innovative therapy Kerendia (finerenone) has received approval in India for the treatment of adult…
PHARMAP 2025 brings together global pharma leaders to discuss innovation and drug safety
Chakravarthi AVPS delivers special address on drug safety and moderates key discussion at PHARMAP 2025, shaping the future of…
CDMO Live 2025 to spotlight the future of pharmaceutical outsourcing in Europe
The event will bring together industry leaders to discuss the evolving role of contract manufacturing in global pharma
FINEARTS-HF trial results in clinically meaningful reduction in the composite endpoint of CV death
The study could be of high clinical value to cardiologists who are seeking an optimal treatment of choice for HF patients, which…
Bayer signs marketing and distribution agreement with Dr Reddy’s for second brand of Vericiguat in…
Under this new partnership, Dr. Reddy’s will market the drug under a second brand name Gantra in India, expanding the reach of…
Bayer, Sun Pharma sign marketing and distribution pact for second brand of Finerenone
Sun Pharma to market the drug under the brand name Lyvelsa
Yasmin and Mirena to take back seat from Bayer’s future drug strategy: GlobalData
The R&D setbacks in the women’s health space have ultimately led to Bayer refocussing its research efforts on oncology,…
Bayer introduces medication for Chronic Kidney Disease
The drug is a non-steroidal, selective mineralocorticoid receptor antagonist indicated for patients with chronic kidney disease…
US FDA approves additional indication of darolutamide in combination with docetaxel
The approval is based on positive results of the phase-III Arasens trial that demonstrated darolutamide plus Androgen Deprivation…